Processing PDF: /home/ngobiro/projects/pngobiro.github.io/colleges/kmtc/diploma/Diploma in Kenya Registered Community Health Nursing/PHAC 1203: Pharmacology/notes/BLOCK 1 PHARMACOLOGY- COMBINED-1/parts/61_PDFsam_BLOCK 1 PHARMACOLOGY- COMBINED-1.pdf
Starting PDF processing...
PDF processing started. ID: 2025_06_04_7b41d6c443405c9900e5g
Polling PDF status (ID: 2025_06_04_7b41d6c443405c9900e5g)...
Attempt 1: Status = split, Progress = 10.0%
Attempt 2: Status = completed, Progress = 100.0%
PDF processing completed successfully.
Fetching MMD result (ID: 2025_06_04_7b41d6c443405c9900e5g)...

--- Converted MMD Start ---
S/E
1) Hypersensitivity reactions - have a cross allergy with penicillins
2) Long-term use can lead to:
thrombocytopenia, neutropenia, Reversible renal damage, Abnormal liver function
3) Opportunistic infections.
4) Cholelithiasis especially with ceftriaxone
5) Intolerance to alcohol - Disulfiram like reaction especially with cefamandole

\section*{CEPHALOSPORINS}
- 1st generation: E.g. cephalexin, cefazolin, cefadroxil, cephadrin
- Uses: bone infections, skin \& soft tissue infections, uncomplicated UTIs.
- $2^{\text {nd }}$ generation: E.g. cefaclor, cefuroxime, cefoxitin, cefamandole, cefotetan
- Uses:
- Intra-abdominal sepsis (caused by anerobes)
- Pelvic inflammatory diseases
- Bronchitis, pneumonia \& otitis media
- $3^{\text {rd }}$ generation: E.g. Ceftriaxone, cefotaxime, ceftazidime, ceftizoxime, cefoperazone, cefixime
Uses:
- Pseudomonas infections
- CNS infections- meningitis due to
H. influenza in children
- Gonorrhea
- Bone infections
- $4^{\text {th }}$ generation: e.g cefepime

Uses: Pneumonia due to multidrug resistant bacteria

Other beta-lactam antibiotics are
© carbajaenéths e.g imipenem;
b). VANCOMYCIN - bacteriocidal, $\beta$ lactamase resistant
Mechanism of action: inhibits bacterial cell wall synthesis.
Administered : IV
Distribution: widely distributed in the body ( enters meninges if they are inflamed).
Elimination: t1/2-8hrs, undergoes Renal excretion.
S/E
- ototoxic - causing tinnitus, deafness.
- Nephrotoxic
- Hypersenstitivy reaction called

64 maculopápular rash (REDMAN

Uses:
- Drug of Choice (DOC) in
pseudomembraneous colitis caused by C.difficile
- Methicillin Resistant Staphylococcal Aureus (MRSA) infections-
- Streptococcal Endocarditis in combination with an aminoglycoside.
- Other inhibitors of cell wall synthesis include: Teicoplanin, fosfomycin, bacitracin, cycloserine.

\section*{NOTE}
- For every class of drugs:
- Mode of action
- At least two examples
- indications
- Side effects
- Nursing considerations
2. Protein synthesis inhibitors
a). Tetracylines- Bacteriostatic

Mechanism: binds reversibly to the 30s ribosomal subunit to inhibit protein synthesis.
E.g. tetracycline, doxycycline, minocyline, chlortetracycline, oxytetracycline,, demeclocycline
Administered - per oral.
Absorption- moderate, impaired in presence of metal ions \& presence of food but doxyclycline and minocyline are completely absorbed.
Distribution: wide including placenta,
67) breastmmilk but not meninges

\section*{S/E}
1) GIT irritation, Diarrhea, opportunistic infections
2) Deposited in growing bones, teeth to cause discoloration and bone deformity.
3) Photosensitivity (especially with Doxycycline)
4) Vit B deficiency -which can cause impaired mucosal degeneration 5) Fetal hepatotoxicity (in pregnant women)
6) Minocycline can cause vestibular disturbance (ataxia, vertigo

\section*{Tetracyclines}
- Contra -indications
-Pregnant or breastfeeding women
-Children below 8 years
-Renally impairment(except doxycycline)
${ }^{-}$Uses:
- Cholera
- Mycoplasma pneumonia
- Chlymydial infections
- Lyme disease
- Rickettsial diseases
- Neisseria meningitidis - Minocyline
only.

\section*{b). AMINOGLYCOSIDES - bactericidal}
- Highly polar compounds with poor penetration into tissues.
- Mechanism: binds 30s ribosomal subunit inhibiting protein synthesis.
- E.g. Gentamycin, Streptomycin, Amikacin, Neomycin, tobramycin, netilmycin, sisomicin, kanamycin,
Adm - Parenteral
Distribution: distributed into most body fluids, but very poor penetration into CSF
Elimination: Short $\mathrm{t}_{1 / 2}$ ( $2-5 \mathrm{hrs}$ ) - hence multiple dosing. Eliminated by the kidneys.

S/E
1). Ototoxicity (vestibular and auditory damage)- deafness, vertigo, ataxia, tinnitus.
2) Nephrotoxicity: reversible, related to dose and length of treatment.
Increased risk with inefficient renal clearance e.g dehydration, impaired renal blood flow, preexisting renal disease, age.
3). Neuromuscular junction blockade - hence can cause
(71) aggravation of myasthenia gravis ${ }_{11: 07 \mathrm{PM}}$

Aminoglycosides.....
Uses:
- Infection with enteric organisms in combination with an agent against anaerobes (metronidazole), pelvic and abdominal infections.
- Bacterial endocarditis in combination with other drugs (penicillins)
- Tuberculosis (streptomycin, is one of the regimens)
- Plague
- Brucellosis
![](https://cdn.mathpix.com/cropped/2025_06_04_7b41d6c443405c9900e5g-12.jpg?height=106&width=1681&top_left_y=1690&top_left_x=57)
- bacterial ij
infection of Skin,
conjunctiva and external ear (topical)
c). SPECTINOMYCIN

Mechanism: inhibits protein
synthesis, binds to 30s subunit of bacterial ribosome.
-Has features very similar to aminoglycosides
Uses: limited to N.gonorrhea resistant or allergic to other preferred drugs.

\section*{d). CHLORAMPHENICOL}

Largely Bacteriostatic.
Mechanism; binds reversibly to the 50s ribosomal subunit inhibiting protein synthesis.
NB. Macrolides and clindamycin bind to the same site and may interfere w/ each others activities
Administration - oral (bitter taste masked by encapsulation), parenteral
Absorption: rapid and complete
Distribution: well into all tissues including brain. Undergoes some protein binding(3050\%)

\section*{Elimination: undergoes liver metabolism Drug interactions}
- It inhibits hepatic enzymes, hence increasing the plasma levels of Warfarin, phenytoin, tolbutamide and chlorpropamide
Uses: only serious infections
1) Empiric (Before Dx) treatment of bacterial meningitis in conjunction with benzylpenicillin
2) Empiric treatment of brain abscess in conjunction with a penicillin
3) Salmonella infections- typhoid (2nd line drug)
4) Bacterial conjunctivitis ( topical)

\section*{CHLORAMPHENICOL....... \\ S/E}
1). Bone marrow depression causing pancytopenia (rare)
2) Grey baby syndrome- vomiting, diarrhea, poor blood flow (flaccid, cold, grey ashen)
3) Hypersensitivity reactions
4) Alteration of GIT flora
5) Hemolytic anemia with G6PDH deficiency
e). MACROLIDE ANTIBIOTICS: Largely bacteriostatic
Mxn: binds to the 50s ribosomal subunit and interferes with protein synthesis.
E.g. Erythromycin, Clarithromycin, Azithromycin.
Administration: - oral
Absorption: good for clarithromycin; food interferes with azithromycin
absorption
Distribution: wide, crosses into placenta, but not into CSF, taken up by
phagocytic cells. Azithromycin is deposited in tissues from where it is released slowly.

\section*{Elimination: t1/2 1-5 hrs}
- Erythromycin and Azithromycin: Biliary excretion (adjust dose in hepatic dysfunction)
- Clarithromycin: liver metabolism and urinary excretion

\section*{S/E}
- 1). Cholestatic jaundice (reversible) erythromycin
- 2) GIT irritation

Drug interactions - Erythromycin and clarithromycin (but not azithromycin) inhibit Cytochrome P450 enzymes. They can increase plasma levels of: Warfarin, Carbamazepine, Theophylline, Oral digoxin, Methylpredisolone

Uses:
Erythromycin (mostly gm +ve bacteria)
- DOC in community acquired pneumonia
- Diphtheria

Azithromycin and Clarithromycin
- DOC in chlamydial infections (cervicitis, urethritis, conjunctivitis)
- Respiratory tract infections (caused by $H$. influenza, atypical pneumonia)
- Soft tissue infections; Toxoplasmosis
- Substitute in persons allergic to penicillins.

Clarithromycin - H.pylori eradication.

\section*{f). LINCOSAMIDES E.g. Clindamycin, Lincomycin}

Mxn: inhibits translocation process in protein synthesis.
Administration- oral and parenteral
Distribution: good penetration into all tissues (bone, abscesses, phagocytic cells) except brain,
Elimination: liver metabolism, urinary and biliary excretion.

\section*{S/E}
1). Pseudomembranous colitis (alteration of normal flora, C. difficile); stop treatment if diarrhea occurs and manage with metronidazole or vancomycin
2) Hypersensitivity
3) GIT irritation
4) Impaired liver function

Uses: Bacteroides fragilis infections abdominal sepsis, dental infections
-Staphylococcal bone and joint infections
-Non-sexually transmitted genital tract infections (combined with an aminoglycoside)

\section*{3. Inhibitors of nucleic acid synthesis}
a). FLOUROQUINOLONES -Bacteriocidal

Mxn: inhibits DNA gyrase (topoisomerase II) hence inhibition of DNA synthesis.
Absorption - good per oral.
$\mathrm{Al}^{3+}, \mathrm{Mg}^{2+}$, sucralfate and ferrous compounds interfere with absorption.
Distribution: achieves effective conc. in a wide range of tissues esp. kidney, lung, prostate, phagocytes.

Elimination: $\mathrm{t}_{1 / 2} 2-10 \mathrm{hrs}$
- Undergoes hepatic metabolism followed by biliary and renal clearance

S/E
1) GIT irritation
2) Hypersensitivity reactions - skin rashes, photosensitivity, anaphylaxis
3) Arthropathy especially in children
4) CNS disturbance - especially with prior CNS pathology or use of theophyllilne or NSAIDS
Caution: don't drive or use machinery when on these drugs.

\section*{FLOUROQUINOLONES USES:}
1) Urinary tract infections
2) GIT infections e.g. Salmonella typhi
3) Respiratory tract infections esp. P.aeruginosa
4) Gonorrhea, cervicitis, Septicemia
6) Osteomyelitis caused by gram-ve bacteria.
E.g. Norfloxacin, Ciprofloxacin, Enoxacin, Ofloxacin, Lomefloxacine, Levofloxacin, Sparfloxacin, Clinafloxacin
C/I
- Children under 18 years
- Pregnancy and lactation.
4. Folic acid synthesis inhibitors
a). SULPHONAMIDES - Bacteriostatic, broad spectrum.
Mxn: Competitively inhibit dihydropteroate synthetase hence interfering with folic acid synthesis.

Administation: oral and topical (eg. silversulphadiazine)
Absorption: rapid for most (e.g.
sulphamethoxazole), poor for sulphasalazine.
Distribution: well into most tissues including CSF, placenta, inflammatory exudates

\section*{Elimination: $\mathrm{t}_{1 / 2}$ varies;}
- Liver metabolism and renal clearance.

\section*{S/E}
1) Hypersenstivity-inform of anaphylaxis, stevens-Johnson syndrome
2) Bone marrow depression (causes macrocytic anemia in high doses, avoid in pregnancy)
3) Crystalluria
4) CNS disturbance
5) Teratogenic ( C/l in pregnancy)

Sulphonamides ..... examples:
Systemic drugs
1. Short acting -sulfisoxazole, sulfamethizole
2. Intermediate acting - sulphamethoxazole, sulfadiazine, sulfadimidine,
3. Long acting - sulfametopyrazine, sulfadoxine.

Non-systemic/local effect
1. Oral nonabsorbable (GIT effect)sulfasalazine.
2. Topical - sulfacetamide (eye), Silver sulfadiazine (burns, wounds), Mefenide (burns, wounds)

\section*{SULPHONAMIDES......}

\section*{Uses: single drug}
1) Silversulphadiazine - (topical) prophylaxis and treatment of infected burns, pressure sores, skin ulcers
2) inflammatory bowel disease sulphasalazine or sulphapyridine + saliclylate
3) some sexually transmitted infections chlamydia, trachoma, chancroid.

\section*{Combined - (Trimethoprim + sulphamethoxazole = co-trimoxazole (septrin)}

Uses of co-trimoxazole
1) Pneumocystis jiroveci pneumonia
2) Toxoplasmosis
3) Norcadiosis (pneumonia and brain abscesses).
4) Chronic urinary tract infections.
5) Chronic bronchitis (2nd line drug)
6) Otitis media (2nd line drug)
7. Enteric bacteria
8. Respiratory infections.)

Dosage (septrin): $960 \mathrm{mg}-1.44 \mathrm{~g}$ BD (P.O)
b). TRIMETHOPRIM: Bacteriostatic and broad specrum.
Mxn: inhibitor of dihydrofolate dreductase leading to the inhibition of DNA synthesis
Administartion: oral
Abs: rapid and complete
Distribution: wide especially prostatic and vaginal fluids
Elimination: $\mathrm{t}_{1 / 2} 10 \mathrm{hrs}$
- Liver metabolism and urinary excretion

Uses: as a single drug
1) Urinary tract infections
2) Respiratory infections
--- Converted MMD End ---
